Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience

Makino Keishi; Nakamura Hideo; Hide Taku-ichiro; Kuroda Jun-ichiro; Yano Shigetoshi; Kuratsu Jun-ichi

首页> 外文期刊>International journal of clinical oncology >Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience

【24h】

Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience

机译：初始大剂量氨甲蝶呤治疗完成对原发性中枢神经系统淋巴瘤的预后影响：单一机构的经验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background This retrospective single-center study assessed the feasibility, outcomes, and side-effects of high-dose methotrexate (HD-MTX) plus procarbazine in the treatment of immunocompetent patients with primary central nervous system lymphoma (PCNSL).

机译：背景这项回顾性单中心研究评估了大剂量甲氨蝶呤（HD-MTX）联合丙卡巴嗪在治疗具有免疫功能的原发性中枢神经系统淋巴瘤（PCNSL）患者中的可行性，结果和副作用。

著录项

来源
《International journal of clinical oncology》 |2015年第1期|共6页
作者
Makino Keishi; Nakamura Hideo; Hide Taku-ichiro; Kuroda Jun-ichiro; Yano Shigetoshi; Kuratsu Jun-ichi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Primary central nervous system lymphoma; High-dose methotrexate; Chemotherapy; Retrospective study; Prognostic impact;

机译：原发性中枢神经系统淋巴瘤;大剂量甲氨蝶呤;化学疗法;回顾性研究;预后影响;

相似文献

外文文献
中文文献
专利

1. Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience [J] . Makino Keishi, Nakamura Hideo, Hide Taku-ichiro, International journal of clinical oncology . 2015,第1期

机译：初始大剂量氨甲蝶呤治疗完成对原发性中枢神经系统淋巴瘤的预后影响：单一机构的经验
2. Comparing the Efficacy of DeVIC Therapy and High-dose Methotrexate Monotherapy with Whole-brain Radiation Therapy for Newly-diagnosed Primary Central Nervous System Lymphoma: A Single Institution Study [J] . Chalise Lushun, Motomura Kazuya, Ohka Fumiharu, Anticancer Research: International Journal of Cancer Research and Treatment . 2017,第9期

机译：比较患者治疗和高剂量甲氨蝶呤单药治疗全脑放射治疗新诊断的原发性神经系统淋巴瘤的疗效：单一机构研究
3. Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: A single-institution experience [J] . Ly K. Ina, Crew Laura L., Graham Carrie A., Oncology letters . 2016,第5aPta2期

机译：大剂量甲氨蝶呤和利妥昔单抗治疗原发性中枢神经系统淋巴瘤：单中心经验
4. Treatment of Recurrent Post-transplant LymphoproIIferative Disorder (PTLD) of the Central Nervous System (CNS) with High-dose Methotrexate (HD-MTX) [C] . Twist C.J., Kjelson L., McKenney A., International Small Bowel Transplant Symposium . 2009

机译：用高剂量甲氨蝶呤（HD-MTX）的中枢神经系统（CNS）复发性移植后移植淋巴结疾病（PTLD）的处理
5. Utility of apparent diffusion coefficients in the evaluation of primary central nervous system lymphoma. [D] . Gilbert, John Webster. 2012

机译：表观扩散系数在原发性中枢神经系统淋巴瘤评估中的应用。
6. Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: A single-institution experience [O] . K. INA LY, LAURA L. CREW, CARRIE A. GRAHAM, -1

机译：大剂量甲氨蝶呤和利妥昔单抗治疗原发性中枢神经系统淋巴瘤：单中心经验
7. Comparing the Efficacy of DeVIC Therapy and High-dose Methotrexate Monotherapy with Whole-brain Radiation Therapy for Newly-diagnosed Primary Central Nervous System Lymphoma: A Single Institution Study [O] . 2017

机译：比较患者治疗和高剂量甲氨蝶呤单药治疗新诊断的原发性神经系统淋巴瘤的疗效和高剂量甲氨蝶呤单药治疗的疗效：单一机构研究

Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience

摘要

著录项

相似文献

相关主题

期刊订阅